Open-label RCT evaluating oral artesunate-clindamycin vs quinine-clindamycin, both given twice daily for 3 days, for the treatment of uncomplicated falciparum malaria in 100 Gabonese children. The activity of artesunate-clindamycin was comparable to that of quinine-clindamycin in the cure rates at day 28 of follow-up.